Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReGen Challenges FDA Report's Facts And Motivation

This article was originally published in The Gray Sheet

Executive Summary

The details of FDA's recent review of ReGen Biologics' Menaflex knee repair device clearance stunned many device industry insiders - but none so much as the company itself

You may also be interested in...



FDA Questions Data Supporting ReGen's Menaflex Ahead Of 510(k) Re-Review

FDA raised concerns about the preclinical and clinical data used to support 510(k) clearance of ReGen Biologic's Menaflex knee repair device ahead of an unprecedented March 23 advisory panel to reconsider FDA's original clearance decision

FDA Questions Data Supporting ReGen's Menaflex Ahead Of 510(k) Re-Review

FDA raised concerns about the preclinical and clinical data used to support 510(k) clearance of ReGen Biologic's Menaflex knee repair device ahead of an unprecedented March 23 advisory panel to reconsider FDA's original clearance decision

FDA To Implement Recommendations From 510(k) Task Force Within Months

FDA plans to implement recommendations from an internal 510(k) task force within months, Office of Device Evaluation Director Donna Bea Tillman said in a Sept. 25 memo to staff

Related Content

Topics

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel